Center News

Caitlin Rivers, PhD, provided testimony at a congressional hearing on the variants SARS-CoV-2 that have emerged and the urgent need to continue to scale up genomic sequencing of COVID-19 cases in the United States.

Experts from the Johns Hopkins Center for Health Security are working with the new COVID Commission Planning Group led by the University of Virginia’s Miller Center of Public Affairs.

Dr. Gigi Gronvall provided expert testimony at a hearing at the California State Assembly on gene synthesis security today.

The Johns Hopkins Center for Health Security released a new report calling on the United States to address the problem of health misinformation and disinformation through a national strategy, to ensure both an effective response to the COVID-19 pandemic and to prepare for the challenges of future public health emergencies.

The Johns Hopkins Center for Health Security and the Regional Centre for Biotechnology of the Department of Biotechnology in the Indian Ministry of Science and Technology co-hosted the seventh United States–India Strategic Dialogue on Biosecurity.

Dr. Gigi Gronvall provided expert testimony at a hearing at the Maryland General Assembly on gene synthesis providers and manufacturers of gene synthesis equipment.

Dr. Crystal Watson provided expert testimony at a congressional hearing on perspectives about the COVID-19 pandemic one year later.

The Johns Hopkins Center for Health Security has released a new special feature in the journal Health Security. This special feature is part of the WHO joint call for articles on infodemics with 5 leading peer-reviewed journals in different fields.

The Johns Hopkins Center for Health Security and its partners, the NPR and Partners In Health, have released data on contact tracers and care resource coordination from their latest joint survey on the state of the national coronavirus contact tracing workforce.

The Johns Hopkins Center for Health Security released a new report on the status of SARS-CoV-2 surveillance, sequencing, and variant characterization and actions the U.S. government should take to increase capacity to respond to new virus variants.